In addition, the finding on the positive impact of PI3K/AKT inhibitor on the apoptotic effects of cisplatin has provided useful information for the design of sensitization strategy in cervical cancer patients, especially those with high levels of LPA. This evidence concerns the gene AKT1 and cervical cancer.